Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations

Completed · Phase 2/Phase 3

Conditions studied: Lymphatic Malformations

In brief

OBJECTIVES: I. Determine the efficacy of picibanil sclerotherapy in children with macrocystic lymphangioma.

Key facts

Study ID

NCT00010452

Run by

University of Iowa

People needed

150

Starts

2000-04-01

Expected to finish

2007-11-01

Last updated by the study team

2015-03-25

Who can join

Age: 1 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Children's Associated Medical Group — San Diego, California, United States
• Children's Hospital of Denver — Denver, Colorado, United States
• Childrens National Medical Center — Washington D.C., District of Columbia, United States
• All Children's Hospital — St. Petersburg, Florida, United States
• University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
• Children's Hospitals and Clinics - Minneapolis — Minneapolis, Minnesota, United States
• SUNY Upstate Medical University — Syracuse, New York, United States
• Oregon Health Sciences University — Portland, Oregon, United States
• Vanderbilt University — Nashville, Tennessee, United States
• Texas Pediatric Otolaryngology Center — Houston, Texas, United States
• Children's Hospital of the Kings Daughter — Norfolk, Virginia, United States
• University of Wisconsin Hospital and Clinics — Madison, Wisconsin, United States
• Children's Hospital of Wisconsin — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.